Meta Platforms Sets October 21 Date for Q3 2026 Financial Results
Meta Platforms confirms it will report Q3 2026 financial results on October 21, 2026, following the market close, with a scheduled conference…
Meta Platforms confirms it will report Q3 2026 financial results on October 21, 2026, following the market close, with a scheduled conference…
Nelnet, Inc. confirms it will report third quarter 2026 financial results after the market close on November 5, 2026, providing investors with…
New clinical data confirms Castle Biosciences' TissueCypher platform provides critical risk stratification for Barrett's esophagus patients, potentially accelerating clinical adoption.
Seres Group showcased its AITO luxury EV series at the Paris Motor Show, confirming plans to enter the European market by 2027…
FIFCO's Imperial brand introduces the 'Es de Ticos' global cultural program, featuring traditional Costa Rican experiences to engage the diaspora, though the…
Equity LifeStyle Properties confirms its Q3 2026 earnings report will be released on October 20, 2026, after the market closes.
Medline rolls out an enhanced TrackPoint inventory platform integrated with PointClickCare to streamline supply chain operations and improve visibility for healthcare facilities.
SERES Group showcases its AITO luxury EV series at the Paris Motor Show, confirming a 2027 European market launch to scale its…
Starwood Property Trust will report its Q3 2026 financial results on November 6, 2026, ahead of the market open, followed by an…
Noble Corporation confirms it will report its third quarter 2026 financial results on October 26, 2026, following the close of market operations.
Johnson & Johnson's TREMFYA demonstrates strong efficacy in Crohn's disease trials, with 94% clinical remission and 61% endoscopic remission, bolstering the company's…
Johnson & Johnson's TREMFYA shows consistent perianal fistula remission in Crohn's disease patients, bolstering the company's pharmaceutical outlook.